|Title: ||Spectrum of copy number changes in low grade paediatric brain tumours detected by comparative genomic hybdidisation|
|Other Titles: ||In: Abstracts from the 14th International Conference on Brain Tumor Research and Therapy. Asheville, North Carolina, USA. May 27-30, 2001. No.180|
|Citation: ||Neuro-oncology, 3(Suppl 1): 310|
|Publisher: ||Society for Neuro-Oncology and Duke University Press|
|Issue Date: ||2001 |
|Additional Links: ||http://neuro-oncology.dukejournals.org/|
|Abstract: ||Several different types of low-grade brain tumours arise predominantly in the paediatric population, including astrocytoma, craniopharygioma and choroid plexus papilloma (CPP). As yet, the genetic events that contribute to their development have not been well defined. We have used comparative genomic hybridisation (CGH) to identify regions of genetic loss and gain in a series of 30 low grade tumours comprising 7 pilocytic astrocytoma (WHO grade I), 12 grade II astrocytoma, 5 craniopharyngioma (WHO grade I) and 6 CPP (WHO grade I). In the group of astrocytoma, there were no detectable regions of genomic imbalance in all 7 grade I tumours and in 9 of 12 grade II tumours. The copy number changes in the remaining 3 cases of grade II astrocytoma were gain of 7p and 12p; loss of 1p, 12q and 22; gain of 2q, 3, 8q and 18q, respectively. Similarly, 4 of 5 craniopharyngioma appeared to have normal CGH profiles, although multiple changes including gain of 4, 6q, 8q and 18q and loss of 17, 20q and 22 were observed in the sixth case. In contrast, copy number aberrations were detected in 3 of 6 CPP. In one tumour, gain of 7 was the sole change, whereas gain of 3q and 6q and loss of 9q and 21 were detected in a second case. However, in the remaining CPP all chromosomes except X and Y were involved in copy number changes with gain of 1, 7, 9, 12, 15, 16, 18, 20 and 22 and loss of the remaining autosomes. Overall, genomic imbalance was detected in only 7 of these low grade tumours and it was not possible to identify consistent regions of loss and gain. Considerably larger numbers of each tumour type need to be analysed in order to elucidate the genetic pathways involved in tumourigenesis.|
|Type: ||Meetings & Proceedings|
|Description: ||Abstracts from Neuro-Oncology are provided here courtesy of Society for Neuro-Oncology and Duke University Press.|
Comparative Genomic Hybridisation
|Appears in Collections: ||Cancer Research Group|
|Files in This Item:|
There are no files associated with this item.
All Items in WIRE are protected by copyright, with all rights reserved, unless otherwise indicated.